tiprankstipranks
Hoth Therapeutics (HOTH)
NASDAQ:HOTH
US Market
Want to see HOTH full AI Analyst Report?

Hoth Therapeutics (HOTH) Income Statement

492 Followers

Hoth Therapeutics Income Statement

Last quarter (Q1 2026), Hoth Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Hoth Therapeutics's net income was $-2.69M. See Hoth Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -66.83K$ 0.00
Operating Expenses
$ 11.11M$ 8.22M$ 7.69M$ 11.07M$ 14.10M
Depreciation and Amortization
$ 0.00$ 8.22M$ 7.69M$ 11.07M$ 0.00
EBITDA
$ -11.11M$ 27.13K$ -153.15K$ 0.00$ -14.10M
Operating Income
$ -11.11M$ -8.22M$ -7.69M$ -11.07M$ -14.10M
Other Income/Expenses
$ -1.36M$ 27.13K$ -153.15K$ -306.40K$ -212.26K
Pretax Income
$ -12.47M$ -8.19M$ -7.85M$ -11.37M$ -14.31M
Net Income
$ -12.47M$ -8.19M$ -7.85M$ -11.68M$ -14.31M
Per Share Metrics
Basic EPS
$ -0.90$ -1.28$ -2.30$ -9.75$ -16.03
Diluted EPS
$ -0.90$ -1.28$ -2.30$ -9.75$ -16.03
Weighted Average Shares Outstanding
13.81M 6.38M 3.41M 1.20M 893.20K
Weighted Average Shares Outstanding (Diluted)
13.81M 6.38M 3.41M 1.20M 893.20K
Currency in USD

Hoth Therapeutics Earnings and Revenue History